• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies.

	Organisation	Bone Therapeutics S.A. (Euronext Brussels + Paris: BOTHE)
	Group	Bone Therapeutics (Group)
	Organisation 2	NewCap. – Investor Relations & Financial Communications
	Product	ALLOB® allogeneic bone cell product
	Product 2	investment banking
	Person	Lienard, Thomas (Bone Therapeutics 201610– Interim CEO joined 201511– as CBO before Lundbeck + Lilly + McKinsey)
	Person 2	Laurent, Pierre (NewCap. 201404 CEO + Owner)

Record changed: 2018-03-22

Advertisement

More documents for Bone Therapeutics (Group)

• [1] Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies....
• [2] Bone Therapeutics S.A.. (11/6/18). "Press Release: Bone Therapeutics Announces Conclusions from Interim Analysis of Phase III PREOB Study in Hip Osteonecrosis". Gosselies....
• [3] Bone Therapeutics S.A.. (10/29/18). "Press Release: Bone Therapeutics Announces Appointment of Linda Lebon as Chief Regulatory Officer". Gosselies....
• [4] Bone Therapeutics S.A.. (9/14/18). "Press Release: Bone Therapeutics Announces Final Results from Phase I/IIA ALLOB Delayed-union Fracture Study". Gosselies....
• [5] Bone Therapeutics S.A.. (4/26/18). "Press Release: Bone Therapeutics Strengthens Board with the Appointment of Claudia D’Augusta as Non-Executive Director". Gosselies....
• [6] Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Announces Private Placement of Convertible Bonds [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies....
• [7] Bone Therapeutics S.A.. (12/15/17). "Press Release: Bone Therapeutics Provides Update on Equity Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies....
• [8] Bone Therapeutics S.A.. (12/14/17). "Press Release: Bone Therapeutics Launches Equity Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies....
• [9] Zelluna Immunotherapy AS. (11/2/17). "Press Release: Zelluna Immunotherapy Appoints Miguel Forte as Chief Executive Officer". Oslo....
• [10] Bone Therapeutics S.A.. (9/22/17). "Press Release: Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB in Japan". Gosselies....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.